… in this paper that was valid at the time of this study. … completed by care staff for each resident
in NHs (RAI-MDS 2.0 35 ) … of chronic lung conditions, cancer, renal failure, diabetes, and …

… RAI-MDS could be a valuable tool in targeting residents for a transition programme from LTC
to community, a validation study of the RAI-MDS … of comorbidities and geriatric conditions. A …

… Developed by InterRAI, both RAI-MDS and RAI-HC are … Among those examined, Parkinson's
disease, diabetes mellitus … of data to demonstrate such effectiveness. It is thus immensely …

… unmarried residents and those with a longer duration of use. … The RAI-MDS 2.0 is administered
to all NH residents shortly … including resident comorbidity or individual chronic conditions) …

… patients residing in long-term care facilities, might cause … range from 0 (no comorbidity)
to 56 (highest comorbidity). … this group prevented us from finding a significant difference. …

… Additionally, comorbid conditions including diabetes, … of activities of daily living (long- form
ADL) scale (RAI-MDS 2.0)(33) … of effectiveness of diagnosis and treatment for UTI in the LTCF …

… impairment or multiple comorbidities. Although studies have … Therefore, we conducted a
companion validation study to … components of the long-term care and postacute care industry, …

… resident; residents were considered frail if their frailty index score was 0.3 or greater. RAI-MDS …
We specifically chose a comparative effectiveness study design to help protect against …

… the individual cost of cancer, heart disease, and diabetes. … the RAI-MDS pain scale to measure
outcomes. Intervention … of research on the effectiveness of pain management strategies or …

… only for residents who had an RAI-MDS 2.0 assessment … more aggressive behaviors, more
comorbidity, and higher mortality … therapy was unlikely given the accuracy of the database, 40 …